Sept 20 (Reuters) - A U.S. appeals court on Friday revived more than 500 lawsuits alleging that Merck & Co (MRK.N), opens new tab failed to warn that its osteoporosis drug Fosamax increased the risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback